Apnimed, Inc.(APMD:US)
Market Cap$707.26M
Key Metrics
Price$17.76
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$328.88M
Total Assets$342.63M
Net Assets$257.59M
Total Debt$46.91M
Key Metrics
Price$17.76
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$328.88M
Total Assets$342.63M
Net Assets$257.59M
Total Debt$46.91M
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|---|
Revenue | $12.08M | $84.81M | $3.13M |
Cost of Revenue | $1.21M | $2.16M | $1.32M |
Gross Profit | $10.87M | $82.65M | $1.81M |
| $22.57M | $14.61M | $28.93M | |
| Research and Development | $9.9M | $8.1M | $23.46M |
| Selling, General, and Administrative | $12.67M | $6.51M | $5.47M |
| Other Operating Expenses | - | - | - |
Operating Income | -$11.7M | $68.04M | -$27.11M |
| $137.82M | $2.33M | $431K | |
| Non-Operating Interest Income | $970K | $218K | $431K |
| Non-Operating Interest Expense | - | - | - |
| Other Income/Expense | $136.85M | $2.11M | - |
Income Before Tax | $126.11M | $70.37M | -$26.68M |
Income Tax | $0 | $0 | $0 |
Net Income | $125.94M | $70.37M | -$28.65M |
Minority Interests | - | - | - |
Preferred Stock Dividends | - | - | - |
Net Income to Common | $125.94M | $70.37M | -$28.65M |
Shares Outstanding (Basic) | 39.82M | 28.76M | 28.76M |
Shares Outstanding (Diluted) | 39.82M | 32.14M | 32.14M |
EPS (Basic) | $3.16 | $2.45 | -$1 |
EPS (Diluted) | $3.16 | $2.12 | -$1 |
EBIT | -$11.7M | $68.04M | -$27.11M |
EBITDA | -$97.08M | $68.05M | -$27.11M |